In addition to chronic hyperglycemia and elevated FFAs, obesity is a major risk factor for T2DM as it desensitizes glucose recipient organs to the action of insulin (obesity-induced IR), leading to increased insulin demand resulting in β-cell dysfunction [72]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.